Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
129,337,627
-
Total 13F shares
-
781,895
-
Share change
-
+215,559
-
Total reported value
-
$798,000
-
Price per share
-
$1.02
-
Number of holders
-
13
-
Value change
-
+$220,145
-
Number of buys
-
9
-
Number of sells
-
2
Institutional Holders of ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) as of Q4 2018
As of 31 Dec 2018,
ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
781,895 shares.
The largest 10 holders included
SABBY MANAGEMENT, LLC, Virtu Financial LLC, Vanguard Group Inc, CITADEL ADVISORS LLC, BARCLAYS PLC, JANE STREET GROUP, LLC, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA SECURITIES, LLC, PANAGORA ASSET MANAGEMENT INC, and MACQUARIE GROUP LTD.
This page lists
13
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.